Akorn Pharmaceuticals - Articles and news items

Allergan receives Paragraph IV notification on Restasis

Industry news / 16 July 2015 / Victoria White

Akorn Pharmaceuticals seeks approval to market a generic version of Allergan’s Restasis from the US Food and Drug Administration FDA…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+